Group 1 - The market shows a structural opportunity with indices rising due to strong performance in select sectors, while over 3000 stocks are experiencing adjustments [1][4] - The rare earth sector is notably strong, with companies like Jiu Wu Gao Ke hitting the daily limit up, supported by supply-demand dynamics and policy focus, alongside increasing demand from the new energy and military sectors [3][4] - The lithium mining sector is also gaining traction, with companies like Fu Miao Technology reaching the daily limit up, driven by a recovery in the new energy supply chain and stable lithium prices [3][4] Group 2 - The military industry is active, with Tian Qin Equipment rising over 12%, reflecting its connection to geopolitical and policy factors, although it may experience volatility [3][4] - Some sectors, such as innovative pharmaceuticals and photovoltaics, are facing declines, indicating a normal market rotation as funds shift focus [3][4] - The overall market dynamics suggest that while some sectors are performing well, others are consolidating, and investors should assess the fundamental support of their holdings [4]

Market Overview - The three major A-share indices experienced fluctuations, with the Shanghai Composite Index rising by 0.34%, the Shenzhen Component Index increasing by 0.30%, and the ChiNext Index up by 0.26%. The North China 50 Index fell by 0.48%. The total trading volume in the Shanghai and Shenzhen markets reached 1,029.3 billion yuan, an increase of 118.3 billion yuan compared to the previous day. Over 3,000 stocks in the market declined [1]. Sector Performance - The rare earth, lithium mining, and military industry sectors saw gains, while the innovative drug and photovoltaic sectors underwent adjustments. The rare earth sector experienced a significant rise, with stocks like Jiuwu High-Tech (300631) hitting the daily limit, and North Rare Earth (600111) reaching a three-year high. The lithium mining sector remained strong, with stocks such as Fumiao Technology and Shengxin Lithium Energy (002240) also hitting the daily limit. The military sector saw Tianqin Equipment (300922) rise over 12%. In contrast, the innovative drug sector faced fluctuations, with stocks like Guangsheng Tang (300436) and Zhijiang Biology dropping over 5%. The photovoltaic sector adjusted, with stocks like Yamaton (002623) falling over 8% [2]. Hot Stocks - The strongest stocks included Upwind New Materials, which achieved an 8-day consecutive limit-up streak [3]. - Other notable stocks with consecutive limit-ups included Haixing Co., Ltd. (603115) with a 3-day streak, and several others with 2-day streaks [4]. Sector Trends - The energy-saving and environmental protection sector led with 8 stocks hitting the daily limit, including Upwind New Materials and Beihua Co., Ltd. [5]. - The robotics concept sector also had 8 stocks hitting the daily limit, with Upwind New Materials and Construction Industry leading [6]. - The "specialized, refined, and innovative" sector saw 8 stocks hitting the daily limit, with Haixing Co., Ltd. and Beihua Co., Ltd. being notable mentions [7]. Emerging Technologies - In the brain-computer interface sector, companies like Yuke Technology and Entropy Technology are involved, following a breakthrough in clinical trials that could benefit patients with speech impairments [10]. - The AI agent sector is gaining attention with companies like Century Tianhong and Yanhua Intelligent, following the release of OpenAI's ChatGPT Agent, which can perform complex tasks [11]. - The silicon energy sector is experiencing significant changes, with the main contract for polysilicon futures rising by 7.49% to 45,700 yuan/ton, marking a new high. The price increase is driven by rising upstream silicon material prices and changes in the profit distribution within the photovoltaic industry [12][13].

2025年上半年，在A+H股及新经济企业密集赴港上市推动下，港交所锣声迭起。 智通财经APP了解到，今年上半年，港股市场共完成了42宗首次公开招股发行，合计募集资金1071亿元 （港元，下同），募资金额同比增长约700%，较2024年全年增幅约22%，募资规模暂列全球第一。值 得一提的是，2025年上半年，全球10大IPO中，有4宗IPO来自香港。 在这一盛况的背后，很大程度源于基石投资者的深度参与。作为港股IPO市场的关键参与主体，其在市 场中的布局与动向，不仅是衡量市场热度的重要指标，更在很大程度上反映了资本对企业价值的深度判 断，同时对新股发行的成功与否以及后续市场表现起着至关重要的作用，因此对其进行分析具有重要的 市场意义。 智通财经APP梳理发现，2025年上半年港股IPO基石投资呈现三大显著特点。 一是基石投资者"扎堆"现象突出。数据显示，42家港股IPO企业中，有36家引入共计189家基石投资者， 占比高达85.71%，这一数字远超往年水平。452.02亿港元的基石投资总额，占全市场超过42%的募资规 模，展现出资本对港股市场的强烈信心。其中，引入5家及以上基石投资者的公司达到16家。宁德时代 ...

Core Viewpoint - The A-share market is expected to maintain a slow upward trend despite short-term fluctuations, with technology stocks playing a significant role in the rebound [1][2]. Market Outlook - The market is likely in a phase of consolidation before a breakout, with two potential paths: continuing the upward trend or consolidating before challenging previous highs [2]. - Three conditions are necessary for a direct challenge to the previous high of 3674 points: implementation of fiscal stimulus policies, continued global environment easing, and sustained increase in trading volume [2]. Sector Highlights - The A-share market in July is anticipated to be driven by event-based themes, with a high likelihood of sector rotation [3]. - Key sectors to watch include: 1. Consumer expansion and domestic demand, with a focus on dairy products, IP consumption, leisure tourism, and medical aesthetics [3]. 2. Robotics, with a shift from humanoid to quadruped and functional robots, presenting opportunities in sensors and controllers [3]. 3. Semiconductor localization, focusing on semiconductor equipment, wafer manufacturing, materials, and IC design [3]. 4. Military industry, with expectations of order recovery and signs of bottoming out in Q1 reports [3]. 5. Innovative pharmaceuticals, which are expected to see a fundamental turning point in 2025 after a period of adjustment [3]. Market Review - The A-share market showed signs of stabilization and resumed an upward trend, with the ChiNext index rising over 1.7% [4]. - More than 3500 stocks rose, indicating a positive earning effect, with leading sectors including defense, telecommunications, electronics, and pharmaceuticals [4].

今年以来，生物医药B类股强势非常，是港股市场备受青睐的概念之一，板块内多达26只概念股录得翻倍上涨，科伦博泰生物-B（06990.HK）、乐普生 物-B（02157.HK）、和铂医药-B（02142.HK）等多股迎来飙升。 而在IPO市场，还有更多创新药企正赶赴港股市场，其中就包括于近期递表的BlissBio Inc.（以下简称"百力司康"），高盛、华泰国际、建银国际是此次 IPO的联席保荐人。 已获多轮融资，高瓴参与投资 说起百力司康就不得不提及其创始人魏紫萍博士和周宇虹博士，这两位创始人均拥有亮眼的学术背景与丰富的业界经验。 根据招股书，魏紫萍博士先后获中国科学技术大学化学学士、新泽西州立罗格斯大学的化学博士学位，曾在阿斯利康（AZN.US）、百时美施贵宝等药企 从事研发和管理相关的工作，在制药业拥有逾25年的药品研发经验。 周宇虹博士先后获得复旦大学生物化学学士学位及遗传学硕士学位、新泽西州立罗格斯大学微生物学及分子遗传学博士学位，曾在Morphotek,Inc.担任抗 体开发高级总监，拥有逾25年的靶向治疗及免疫治疗研发经验。 2017年，魏紫萍博士和周宇虹博士创办了百力司康，总部位于杭州。百力司康是 ...

Core Insights - The report emphasizes the importance of discovering investment opportunities with a proactive attitude rather than merely relaying information [1] Macro News Summary - The Ministry of Commerce is promoting the expansion of pilot programs in the telecommunications and healthcare sectors, while also cautiously expanding self-initiated openings in education and culture [4] - The central government has set new directions for urban development, focusing on urban renewal and real estate development [5] Industry Latest Developments - A record high for single order amounts has been achieved, indicating a potential acceleration in the commercialization of the low-altitude economy, with related stocks including Nanjing Julong (300644) and Yingboer (300681) [6] - The national maximum electricity load has reached a new historical high, suggesting continued positive performance for the electricity sector, with related stocks such as Shanghai Electric (600021) and Jinkong Electric (000767) [6] - A brain-computer interface technology developer conference is scheduled for August, which may catalyze related sectors, with stocks like Innovation Medical (002176) and Aipeng Medical (300753) being relevant [6] Company Focus - Chongda Technology (002815) is experiencing strong domestic and international order demand [7] - Guoxuan High-Tech (002074) has received EU battery regulation compliance certification for its 5MWh liquid-cooled energy storage system [7] - East Asia Machinery (301028) anticipates increased demand for air compressors and vacuum pumps due to accelerated domestic substitution processes [7] - Jinxin Technology (300252) has developed products compatible with Intel's next-generation platform Oak Stream (PCIE 6.0) [7] Market Review and Outlook - On July 17, the market experienced an overall upward trend, with the ChiNext Index leading gains. The total trading volume in the Shanghai and Shenzhen markets reached 1.54 trillion, an increase of 97.3 billion from the previous trading day [8] - The report highlights several investment opportunities, including: 1. Technology innovation sectors such as robotics, AI, semiconductors, and digital economy (digital currency), with a caution to avoid purely speculative stocks with high valuations [8] 2. Anti-involution sectors including photovoltaics, batteries, energy storage, new energy vehicles, building materials, coal, steel, and non-ferrous metals [8] 3. Areas benefiting from consumption upgrades and policies, including innovative pharmaceuticals, consumer healthcare, equipment upgrades, smart homes, cross-border e-commerce, and industrial upgrades [8]

Core Insights - The report highlights the significant growth potential in the measurement and calibration industry, driven by new policies aimed at enhancing manufacturing capabilities in China [6][7][8] - The renewable energy sector, particularly in electric power equipment, is poised for growth due to supportive policies in the UK and increasing demand for energy storage solutions [13] - The pharmaceutical industry is recommended for investment, focusing on innovative drugs and their supply chains, with strong support from health insurance reforms [14] Industry and Company Analysis - **Measurement and Calibration Industry**: The first policy document from the Ministry of Industry and Information Technology emphasizes the need for precise measurement to drive innovation in manufacturing. This includes establishing a service network and digital transformation paths, with a focus on high-level calibration institutions and digital measurement software [6][7] - **Renewable Energy Sector**: The UK government has restarted subsidies for electric vehicles and charging infrastructure, indicating a robust market for energy storage systems. The report suggests focusing on companies involved in battery production and charging infrastructure, such as Ningde Times and Keda Technology [13] - **Pharmaceutical Industry**: The report continues to recommend innovative drug sectors, highlighting the recent adjustments in health insurance and commercial insurance that favor high-value innovative drugs. Companies like Kelun-Biotech and Innovent Biologics are noted for their strong potential in both domestic and international markets [14] - **Oil and Gas Sector**: China National Offshore Oil Corporation (CNOOC) has made significant advancements in oil and gas exploration, achieving record production levels in both domestic and international operations. The report anticipates continued growth in production capacity, particularly in the Stabroek block in Guyana [20][21][24]

Group 1 - The adjustment of the medical insurance catalog and commercial health insurance innovative drug catalog has officially started, providing stronger economic support for the development of innovative drugs in China [1] - Domestic and overseas markets for innovative drugs are showing continuous improvement, with promising clinical data presented at academic conferences such as ASCO and ADA [1] - The trend of Chinese innovative drugs going abroad is strengthening as their clinical data and progress become increasingly competitive globally [1] Group 2 - The CXO industry is experiencing a recovery, with prices in preclinical CRO, clinical CRO, and domestic CDMO businesses stabilizing, and new orders steadily recovering [2] - The international CDMO business maintains a reasonable pricing system, and the impact of high pandemic baselines has been digested, indicating a potential industry reversal [2] - Chinese companies have comprehensive advantages in the small molecule CRDMO sector, and their industry position is unlikely to be shaken in the medium term [2][3] Group 3 - The overall market share of Chinese companies in the large molecule CRDMO sector remains low, facing strong competition from international players [3] - The rapid development of new molecular businesses such as peptides, oligonucleotides, and CGT is expected to further open up growth opportunities in the CXO sector [3]

Group 1: Report Industry Investment Rating - No information provided on the report industry investment rating Group 2: Core View - On July 17, all four major stock index futures contracts for the current month rose. IF rose 0.74%, IH rose 0.37%, IC rose 1.17%, and IM rose 1.41%. The overall sentiment in the stock index futures market remains positive in the absence of negative news [1]. - The total trading volume of stock index futures rebounded on this trading day, indicating an increase in investors' trading enthusiasm. The A - share market fluctuated upwards, with the ChiNext Index surging, and theme stocks blooming in multiple areas. The computing power industry chain led the gains [1][2][6]. Group 3: Summary by Relevant Catalogs 3.1期指期现数据跟踪 - **IF Contracts**: The closing prices of IF2507, IF2508, IF2509, and IF2512 all rose, with increases of 0.74%, 0.90%, 0.93%, and 0.86% respectively. The trading volumes of IF2507 decreased by 3881, while those of IF2508, IF2509 increased by 6646 and 4243 respectively. The open interests of IF2507 decreased by 8803, while those of IF2508, IF2509, and IF2512 increased [1]. - **IH Contracts**: The closing prices of IH2507, IH2508, IH2509, and IH2512 all rose, with increases of 0.37%, 0.36%, 0.39%, and 0.42% respectively. The trading volume of IH2507 decreased by 2826, while those of IH2508 increased by 4245. The open interests of IH2507 decreased by 4717, while those of IH2508, IH2509, and IH2512 increased [1]. - **IC Contracts**: The closing prices of IC2507, IC2508, IC2509, and IC2512 all rose, with increases of 1.17%, 1.27%, 1.33%, and 1.31% respectively. The trading volume of IC2507 decreased by 9192, while those of IC2508, IC2509, and IC2512 increased. The open interests of IC2507 decreased by 13453, while those of IC2508, IC2509, and IC2512 increased [1]. - **IM Contracts**: The closing prices of IM2507, IM2508, IM2509, and IM2512 all rose, with increases of 1.41%, 1.42%, 1.42%, and 1.38% respectively. The trading volume of IM2507 decreased by 5989, while those of IM2508, IM2512 increased. The open interests of IM2507 decreased by 11744, while those of IM2508, IM2509, and IM2512 increased [1]. 3.2期指前20大会员持仓增减 - For IF contracts, the long - position changes varied among different contracts. For example, IF2507 had a decrease of 5135 in long - positions, while IF2508 had an increase of 7879. The short - position changes also differed, such as IF2507 having a decrease of 5921 [5]. - For IH contracts, IH2507 had a decrease of 3596 in long - positions and a decrease of 3491 in short - positions. IH2508 had an increase of 4081 in long - positions and an increase of 4524 in short - positions [5]. - For IC contracts, IC2507 had a decrease of 9941 in long - positions and a decrease of 10434 in short - positions. IC2508 had an increase of 7871 in long - positions and an increase of 7792 in short - positions [5]. - For IM contracts, IM2507 had a decrease of 7609 in long - positions and a decrease of 8680 in short - positions. IM2508 had an increase of 7929 in long - positions and an increase of 8536 in short - positions [5]. 3.3趋势强度 - The trend strength of IF and IH is 1, and the trend strength of IC and IM is also 1. The trend strength ranges from - 2 to 2, with - 2 being the most bearish and 2 being the most bullish [6]. 3.4重要驱动 - Potential Fed Chairman candidate Kevin Warsh believes that Trump's public pressure on the Fed is correct. The Fed has stepped into policy areas beyond its scope under Powell's leadership and should not overly worry about inflation caused by Trump's tariffs [6]. - The EU is drafting a tariff list on US service industries in preparation for an escalation of the trade war. If negotiations fail, the EU plans to levy fees on US digital services such as advertising services [6]. - The A - share market fluctuated upwards. The Shanghai Composite Index rose 0.37%, the Shenzhen Component Index rose 1.43%, and the ChiNext Index rose 1.75%. The A - share trading volume reached 1.56 trillion yuan, compared with 1.46 trillion yuan the previous day. The computing power industry chain exploded again, with CPO and PCB sectors leading the gains [6].

鹏华产业升级混合型证券投资基金 基金管理人：鹏华基金管理有限公司 基金托管人：宁波银行股份有限公司 报告送出日期：2025 年 7 月 18 日 鹏华产业升级混合 2025 年第 2 季度报告 §1 重要提示 基金管理人的董事会、董事保证本报告所载资料不存在虚假记载、误导性陈述或重大遗漏， 并对其内容的真实性、准确性和完整性承担个别及连带的法律责任。 基金托管人宁波银行股份有限公司根据本基金合同规定，于 2025 年 07 月 17 日复核了本报告 中的财务指标、净值表现和投资组合报告等内容，保证复核内容不存在虚假记载、误导性陈述或 者重大遗漏。 基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证基金一定盈利。 基金的过往业绩并不代表其未来表现。投资有风险，投资者在作出投资决策前应仔细阅读本 基金的招募说明书及其更新。 本报告中财务资料未经审计。 本报告期自 2025 年 04 月 01 日起至 2025 年 06 月 30 日止。 §2 基金产品概况 基金简称 鹏华产业升级混合 基金主代码 011568 基金运作方式 契约型开放式 基金合同生效日 2021 年 9 月 2 日 报告期末基金 ...